Who can use Strensiq(asfotase alfa)?

The specific medical conditions the drug is approved to treat.

Approved Uses

STRENSIQ is indicated for the treatment of patients with perinatal/infantile-onset and juvenile-onset hypophosphatasia (HPP). This encompasses the severe forms of the disease that manifest at birth or in early infancy, as well as the form that presents later in childhood, addressing the core enzyme deficiency responsible for the debilitating skeletal and respiratory complications.